Curated News
By: NewsRamp Editorial Staff
May 09, 2025
Nutriband Innovates Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
TLDR
- Nutriband's AVERSA(TM) technology provides a competitive edge in abuse-deterrent transdermal fentanyl delivery.
- Strategic milestones with partner Kindeva position Nutriband for long-term growth in the opioid crisis solution market.
- Advancement in safer opioid delivery methods with Nutriband's technology aims to reduce misuse and improve public health globally.
- Recent FDA regulatory changes emphasize the importance of safer opioid solutions, creating a compelling market opportunity for innovation.
Impact - Why it Matters
This news matters as it highlights the advancements in abuse-deterrent drug technology in response to the growing opioid crisis. The FDA regulatory changes and the development of safer opioid alternatives are crucial steps towards addressing the challenges of opioid misuse and addiction.
Summary
Nutriband’s AVERSA(TM) technology is advancing toward commercialization as the first abuse-deterrent transdermal fentanyl patch. Recent FDA regulatory changes underscore the urgent need for safer opioid delivery methods and responsible prescribing. Strategic milestones with partner Kindeva and a strengthened global IP portfolio position Nutriband for long-term growth.
The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. The FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers are now required to include prepaid mail-back envelopes for safe disposal of unused medications, while enhanced boxed warnings on opioid labels further reinforce the dangers of misuse, addiction, and overdose.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Nutriband Innovates Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
